Abbott Laboratories

Market Cap (Mar-08-2026)

190.381 Billion USD

World Rank (Jan-05-2024)

57

Market Cap (Jan-05-2024)

192.668 Billion USD

World Rank (Jul-30-2023)

57

Market Cap (Jul-30-2023)

196.030 Billion USD

World Rank (Jan-07-2022)

43

Market Cap (Jan-07-2022)

239.710 Billion USD

World Rank (Jan-01-2021)

49

Market Cap (Jan-01-2021)

194.060 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 34

Headquarters Country

USA

Nasdaq / NYSE Code

ABT

CEO

Robert Ford

Founders

Wallace Calvin Abbott

Employee Count

115,000

Employee Count as of Date

As on Dec-2022

Headquarters City/State

Illinois

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

44,328 Million USD

Annual Operating Income in USD

8,053 Million USD

Annual Net Income in USD

6,524 Million USD

Annual Results for Period Ending

Dec-2025 ending year

Total Assets in USD

86,713 Million USD

Total Liabilities in USD

33,942 Million USD

Total Equity in USD

52,771 Million USD

Balance Sheet for Period Ending

Dec-2025 ending year

Business Sector

Company Website

Abbott - Healthcare and Pharmaceutical Company

Wikipedia

Yahoo

Yahoo @ NYSE

Facebook

Company Profile

Abbott Laboratories is USA based healthcare and pharmaceutical and is multi-national company. Abbott has presence in more than 150 countries. Key working areas of Abbott are related to Diabetes, Diagnostics, Neuro Modulation, Nutrition, Pharmaceuticals. They have over 113,000 employees as on 2021. Headquarters is in USA.

Facts About Company

As on 2022, Abbott Laboratories has 115,000 employees.

Abbott Laboratories annual revenue generated for period ending Dec-2022 was 43,653 million USD.

Abbott Laboratories annual net income generated for period ending Dec-2022 was 6,933 million USD.

Abbott Laboratories annual revenue generated for period ending Dec-2021 was 43,075 million USD.

Abbott Laboratories annual net income generated for period ending Dec-2021 was 7,071 million USD.

Total Assets as on Dec-2021 was 75,196 Million USD.

Annual Results Summary

Abbott Laboratories - Yearly Revenue and Net Profit - in Million USD:

Fiscal Year	Fiscal Year End	Total Annual Revenue (USD mm)	*Gross Profit (USD mm)**	Operating Profit (USD mm)	Net Income (USD mm)	Revenue YoY	Gross Margin	Operating Margin	Net Margin
2025	2025-12-31	44,328	25,009	8,053	6,524	5.7%	56.4%	18.2%	14.7%
2024	2024-12-31	41,950	23,244	6,825	13,402	4.6%	55.4%	16.3%	31.9%
2023	2023-12-31	40,109	22,134	6,478	5,723	(8.1%)	55.2%	16.2%	14.3%
2022	2022-12-31	43,653	24,511	8,362	6,933	1.3%	56.1%	19.2%	15.9%
2021	2021-12-31	43,075	24,538	8,425	7,071	24.5%	57.0%	19.6%	16.4%
2020	2020-12-31	34,608	19,605	5,357	4,495	8.5%	56.6%	15.5%	13.0%
2019	2019-12-31	31,904	18,673	4,532	3,687	4.3%	58.5%	14.2%	11.6%
2018	2018-12-31	30,578	17,872	3,650	2,368	11.6%	58.4%	11.9%	7.7%
2017	2017-12-31	27,390	14,981	1,564	477	31.3%	54.7%	5.7%	1.7%
2016	2016-12-31	20,853	11,759	3,185	1,400	-	56.4%	15.3%	6.7%

Balance Sheet Summary

Abbott Laboratories - Balance Sheet Summary - in Million USD:

Fiscal Year	Total Assets (USD million)	Total Liabilities (USD million)	Total Equity (USD million)
2025	86,713	33,942	52,771
2024	81,414	33,513	47,901
2023	73,214	34,387	38,827
2022	74,438	37,533	36,905
2021	75,196	39,172	36,024
2020	72,548	39,545	33,003
2019	67,887	36,586	31,301
2018	67,173	36,451	30,722
2017	76,250	45,152	31,098
2016	52,666	31,940	20,726

Founded Year

1888

Institutional Investors

Top 30 Institutional Investors in ABBOTT LABORATORIES as on SEP-30-2022

RANK	INSTITUTION NAME	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	VANGUARD GROUP INC	09/30/2023	15,57,65,341	28,065	0.02%	$15,265,003
2	BLACKROCK INC.	09/30/2023	13,63,91,604	-7,61,941	-0.56%	$13,366,377
3	CAPITAL RESEARCH GLOBAL INVESTORS	09/30/2023	7,90,60,836	18,35,578	2.38%	$7,747,962
4	STATE STREET CORP	09/30/2023	7,32,33,207	-15,83,902	-2.12%	$7,176,854
5	CAPITAL INTERNATIONAL INVESTORS	09/30/2023	6,28,36,937	36,58,330	6.18%	$6,158,020
6	MORGAN STANLEY	09/30/2023	3,56,40,402	-7,42,792	-2.04%	$3,492,759
7	GEODE CAPITAL MANAGEMENT, LLC	09/30/2023	3,24,23,419	5,44,462	1.71%	$3,177,495
8	WELLINGTON MANAGEMENT GROUP LLP	09/30/2023	3,12,08,711	12,98,219	4.34%	$3,058,454
9	NORTHERN TRUST CORP	09/30/2023	2,30,16,235	3,43,559	1.52%	$2,255,591
10	NORGES BANK	12/31/2022	1,72,48,522	10,12,058	6.23%	$1,690,355
11	JPMORGAN CHASE & CO	09/30/2023	1,67,35,021	17,60,322	11.76%	$1,640,032
12	WELLS FARGO & COMPANY/MN	09/30/2023	1,65,89,120	-4,95,913	-2.90%	$1,625,734
13	BANK OF AMERICA CORP /DE/	09/30/2023	1,62,76,097	-10,29,386	-5.95%	$1,595,058
14	BANK OF NEW YORK MELLON CORP	09/30/2023	1,46,03,003	-5,69,235	-3.75%	$1,431,094
15	MASSACHUSETTS FINANCIAL SERVICES CO /MA/	09/30/2023	1,35,96,988	-45,51,738	-25.08%	$1,332,505
16	STATE FARM MUTUAL AUTOMOBILE INSURANCE CO	09/30/2023	1,35,87,118	0	0%	$1,331,538
17	POLEN CAPITAL MANAGEMENT LLC	09/30/2023	1,34,80,736	-3,81,118	-2.75%	$1,321,112
18	LEGAL & GENERAL GROUP PLC	09/30/2023	1,24,25,839	-4,07,288	-3.17%	$1,217,732
19	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	09/30/2023	1,21,53,877	32,157	0.27%	$1,191,080
20	NUVEEN ASSET MANAGEMENT, LLC	09/30/2023	1,20,79,884	-5,04,217	-4.01%	$1,183,829
21	ALLIANCEBERNSTEIN L.P.	09/30/2023	1,08,82,778	7,20,015	7.09%	$1,066,512
22	AMERIPRISE FINANCIAL INC	09/30/2023	1,07,38,369	-12,12,030	-10.14%	$1,052,360
23	FISHER ASSET MANAGEMENT, LLC	09/30/2023	96,94,131	25,119	0.26%	$950,025
24	JANUS HENDERSON GROUP PLC	09/30/2023	94,38,083	-2,23,003	-2.31%	$924,932
25	FLOSSBACH VON STORCH AG	09/30/2023	90,13,790	7,41,441	8.96%	$883,351
26	GOLDMAN SACHS GROUP INC	09/30/2023	87,95,608	1,07,048	1.23%	$861,970
27	FRANKLIN RESOURCES INC	09/30/2023	81,86,315	1,35,316	1.68%	$802,259
28	AMUNDI	09/30/2023	76,09,077	8,13,944	11.98%	$745,690
29	UBS ASSET MANAGEMENT AMERICAS INC	09/30/2023	73,95,681	-99,02,729	-57.25%	$724,777
30	UBS GROUP AG	09/30/2023	72,35,054	40,440	0.56%	$709,035